Mistletoe as complementary treatment in patients with advanced non-small-cell lung cancer treated with carboplatin-based combinations: A randomised phase II study
Authors:
- Gil Bar-SelaGBGil Bar-Sela
- Mira WollnerMWMira Wollner
- Liat HammerLHLiat Hammer
- Abed AgbaryaAAAbed Agbarya
- Elizabeth DudnikEDElizabeth Dudnik
- Nissim HaimNHNissim Haim
- 1 March 2013
- journal article
- research article
- Published by Elsevier in European Journal of Cancer
- Vol. 49 (5) , 1058-1064
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Assessment of Extracts from Mistletoe (Viscum album) for Herb–Drug Interaction by Inhibition and Induction of Cytochrome P450 ActivitiesPhytotherapy Research, 2011
- Survival of cancer patients treated with mistletoe extract (Iscador): a systematic literature reviewBMC Cancer, 2009
- Use of complementary and alternative medicine in cancer patients: a European surveyAnnals of Oncology, 2005
- Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomesLung Cancer, 2005
- Randomized Phase III Study of Gemcitabine and Vinorelbine Versus Gemcitabine, Vinorelbine, and Cisplatin in the Treatment of Advanced Non-Small-Cell Lung Cancer: From the German and Swiss Lung Cancer Study GroupJournal of Clinical Oncology, 2004
- Mistletoe Therapy in Oncology2001
- The effect of an adjuvant mistletoe treatment programme in resected head and neck cancer patientsEuropean Journal of Cancer, 2001
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI: Journal of the National Cancer Institute, 2000
- The EORTC QLQ-LC13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trialsEuropean Journal of Cancer, 1994
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI: Journal of the National Cancer Institute, 1993